Plain-English translation of NCT05908708 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes research guide →This study is tracking how well the Medtronic 780G closed-loop insulin pump system works for children and teenagers with type 1 diabetes. The 780G is a smart insulin pump that automatically adjusts insulin delivery based on your blood sugar levels. Researchers want to compare how you do on this system compared to whatever insulin management you were using before.
Type 1 diabetes requires constant careful management to keep blood sugar in a safe range. Closed-loop systems like this medication are designed to do some of that work automatically, which could reduce stress on families and help young people avoid dangerous low or high blood sugar episodes.
You likely qualify if…
You likely don't qualify if…
If you join, you'll use the 780G system as part of your regular diabetes care. Researchers will collect information from your clinic visits and your pump's data at six timepoints over two years: at the start, then at 1 month, 3 months, 6 months, 1 year, and 2 years. The data collected comes from your routine medical records and what your pump and glucose monitor already track—there's nothing extra you have to do.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Israel
Collaborators
Tel-Aviv Sourasky Medical Center, Maccabi Healthcare Services, Israel
Enrollment target
~120 participants
Started
June 2023
Primary completion
July 2026
Age range
1 Year – 21 Years
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Noah Gruber, MD
Sheba Medical Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.